CoreValve Advance International Post Market Study

NCT01074658 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1015

Last updated 2017-12-02

Study results available
· View outcomes & findings →

Summary

The CoreValve Advance study is intended to evaluate the clinical utility of the Medtronic CoreValve System in a "Real-World" patient population.

Conditions

  • Severe Aortic Stenosis

Interventions

DEVICE

Medtronic CoreValve System

Transcatheter Aortic Valve Implantation of the Medtronic CoreValve System

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Axel Linke, Prof Dr med · Universitat Leipzig Herzzentrum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-11-30
Completion
2017-05-31

Countries

  • Belgium
  • Colombia
  • Denmark
  • France
  • Germany
  • Greece
  • Israel
  • Italy
  • Netherlands
  • Portugal
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01074658 on ClinicalTrials.gov